Company profile CMPX
After 34 days of this quarter the interest is at 51.0. Based on that we can calculate that during remaining 58 days it will total up to 138.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 166 inf% YoY inf% QoQ | 316 inf% YoY 90.4% QoQ |
| 2021 | 132 inf% YoY -58.2% QoQ | 126 inf% YoY -4.5% QoQ | 209 25.9% YoY 65.9% QoQ | 142 -55.1% YoY -32.1% QoQ |
| 2022 | 173 31.1% YoY 21.8% QoQ | 191 51.6% YoY 10.4% QoQ | 89 -57.4% YoY -53.4% QoQ | 206 45.1% YoY 131.5% QoQ |
| 2023 | 164 -5.2% YoY -20.4% QoQ | 209 9.4% YoY 27.4% QoQ | 110 23.6% YoY -47.4% QoQ | 51 -75.2% YoY -53.6% QoQ |
The average 5 years interest of Compass Therapeutics was 8.75 per week. The last year interest of Compass Therapeutics compared to the last 5 years has changed by 46.63%. This is something to be checked. This didn't exist 5 years ago.
There is not enough data for Compass Therapeutics CTX-009 to provide analysis
There is not enough data for Compass Therapeutics CTX-009 to provide correlation calculation
There is not enough data for Compass Therapeutics CTX-009 to provide analysis
There is not enough data for Compass Therapeutics CTX-471 to provide analysis
There is not enough data for Compass Therapeutics CTX-471 to provide correlation calculation
There is not enough data for Compass Therapeutics CTX-471 to provide analysis
There is not enough data for Compass Therapeutics oncology to provide analysis
There is not enough data for Compass Therapeutics oncology to provide correlation calculation
There is not enough data for Compass Therapeutics oncology to provide analysis
There is not enough data for Compass Therapeutics CD137 to provide analysis
There is not enough data for Compass Therapeutics CD137 to provide correlation calculation
There is not enough data for Compass Therapeutics CD137 to provide analysis
Google Trends for Compass Therapeutics biopharmaceuticals
Not enough data for reliable calculations!
There is not enough data for Compass Therapeutics biopharmaceuticals to provide analysis
There is not enough data for Compass Therapeutics biopharmaceuticals to provide correlation calculation
There is not enough data for Compass Therapeutics biopharmaceuticals to provide analysis
After 34 days of this quarter the interest is at 13.0. Based on that we can calculate that during remaining 58 days it will total up to 35.0. Compass Therapeutics stock expected interest is significantly lower compared to previous quarter (-66.0%) and same quarter last year (-68.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 67 |
| 2019 | 96 43.3% QoQ | 19 -80.2% QoQ | 70 268.4% QoQ | 46 -31.3% YoY -34.3% QoQ |
| 2020 | 37 -61.5% YoY -19.6% QoQ | 74 289.5% YoY 100.0% QoQ | 68 -2.9% YoY -8.1% QoQ | 102 121.7% YoY 50.0% QoQ |
| 2021 | 47 27.0% YoY -53.9% QoQ | 70 -5.4% YoY 48.9% QoQ | 134 97.1% YoY 91.4% QoQ | 103 1.0% YoY -23.1% QoQ |
| 2022 | 65 38.3% YoY -36.9% QoQ | 16 -77.1% YoY -75.4% QoQ | 236 76.1% YoY 1375.0% QoQ | 110 6.8% YoY -53.4% QoQ |
| 2023 | 100 53.8% YoY -9.1% QoQ | 97 506.2% YoY -3.0% QoQ | 103 -56.4% YoY 6.2% QoQ | 13 -88.2% YoY -87.4% QoQ |
The average 5 years interest of Compass Therapeutics stock was 6.41 per week. The last year interest of Compass Therapeutics stock compared to the last 5 years has changed by 10.76%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 46.39%.
There is not enough data for Compass Therapeutics careers to provide analysis
There is not enough data for Compass Therapeutics careers to provide correlation calculation
There is not enough data for Compass Therapeutics careers to provide analysis
There is not enough data for Compass Therapeutics Boston to provide analysis
There is not enough data for Compass Therapeutics Boston to provide correlation calculation
There is not enough data for Compass Therapeutics Boston to provide analysis
After 39 days of this quarter the interest is at 127.0. Based on that we can calculate that during remaining 52 days it will total up to 296.0. Compass Therapeutics -stock -company expected interest is significantly higher compared to previous quarter (+190.2%) and same quarter last year (+134.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 94 | 132 40.4% QoQ | 43 -67.4% QoQ | 97 125.6% QoQ |
| 2020 | 33 -64.9% YoY -66.0% QoQ | 124 -6.1% YoY 275.8% QoQ | 74 72.1% YoY -40.3% QoQ | 193 99.0% YoY 160.8% QoQ |
| 2021 | 65 97.0% YoY -66.3% QoQ | 45 -63.7% YoY -30.8% QoQ | 96 29.7% YoY 113.3% QoQ | 57 -70.5% YoY -40.6% QoQ |
| 2022 | 75 15.4% YoY 31.6% QoQ | 73 62.2% YoY -2.7% QoQ | 118 22.9% YoY 61.6% QoQ | 98 71.9% YoY -16.9% QoQ |
| 2023 | 126 68.0% YoY 28.6% QoQ | 89 21.9% YoY -29.4% QoQ | 81 -31.4% YoY -9.0% QoQ | 102 4.1% YoY 25.9% QoQ |
| 2024 | 127 0.8% YoY 24.5% QoQ | - | - | - |
The average 5 years interest of Compass Therapeutics -stock -company was 7.44 per week. The last year interest of Compass Therapeutics -stock -company compared to the last 5 years has changed by 15.32%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 17.37%.